Author - David Miller

PASADENA, Calif.–(BUSINESS WIRE)–Jan. 17, 2025– Arrowhead Pharmaceuticals, Inc. (NASDAQ:...

NEEDHAM, Mass., Jan. 23, 2025 /PRNewswire/ — Stealth BioTherapeutics Inc. (the “Company” or...

ROSWELL, Ga, DUBLIN and HAMILTON, Bermuda, January 28, 2025 – Saol Therapeutics, a privately...

BRIDGEWATER, N.J., Feb. 6, 2025 /PRNewswire/ — Insmed Incorporated (Nasdaq: INSM), a...

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Jan. 29, 2025– Scholar Rock (NASDAQ: SRRK), a...

CINCINNATI- February 10, 2025 –LIB Therapeutics Inc. (LIB), a privately-held, late-stage...

TARRYTOWN, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ:...

NEW HAVEN, Conn., Feb. 11, 2025 /PRNewswire/ — Biohaven Ltd. (NYSE: BHVN) (Biohaven or the...

DURHAM, N.C., Feb. 18, 2025 (GLOBE NEWSWIRE) — Chimerix (NASDAQ: CMRX), a biopharmaceutical...

WARREN, N.J., Feb. 19, 2025 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) announced...